Lucid Diagnostics Inc.
LUCD
$1.39
$0.118.59%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 1.17M | 976.00K | 1.00M | 1.04M | 783.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 1.17M | 976.00K | 1.00M | 1.04M | 783.00K |
Cost of Revenue | 1.68M | 1.61M | 1.66M | 1.46M | 1.63M |
Gross Profit | -512.00K | -638.00K | -655.00K | -417.00K | -851.00K |
SG&A Expenses | 9.41M | 9.08M | 8.26M | 8.61M | 8.16M |
Depreciation & Amortization | 105.00K | 105.00K | 155.00K | 505.00K | 505.00K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 12.87M | 12.17M | 11.79M | 12.49M | 11.91M |
Operating Income | -11.69M | -11.19M | -10.79M | -11.45M | -11.13M |
Income Before Tax | -12.37M | -11.01M | -10.61M | -10.83M | -14.21M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -12.37M | -11.01M | -10.61M | -10.83M | -14.21M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -12.37M | -11.01M | -10.61M | -10.83M | -14.21M |
EBIT | -11.69M | -11.19M | -10.79M | -11.45M | -11.13M |
EBITDA | -11.48M | -10.96M | -10.29M | -10.82M | -10.50M |
EPS Basic | -0.25 | -0.23 | -0.40 | -0.26 | -0.34 |
Normalized Basic EPS | -0.14 | -0.14 | -0.15 | -0.17 | -0.17 |
EPS Diluted | -0.25 | -0.23 | -0.40 | -0.26 | -0.34 |
Normalized Diluted EPS | -0.14 | -0.14 | -0.15 | -0.17 | -0.17 |
Average Basic Shares Outstanding | 50.37M | 48.21M | 45.01M | 42.35M | 41.86M |
Average Diluted Shares Outstanding | 50.37M | 48.21M | 45.01M | 42.35M | 41.86M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |